✦ LIBER ✦

482 POSTER c-FLIP regulates the interaction between interferon-gamma and doxorubicin in breast cancer cells

✍ Scribed by K. Rogers; M. Thomas; P. Johnston; D. Longley

Book ID: 118624110
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 56 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70487-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Direct interaction between BRCA1 and the

Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells

✍ Kawai, Hideki; Li, Huchun; Chun, Philip; Avraham, Shalom; Avraham, Hava Karsenty 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 224 KB

An unexpected biochemical and functional

An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells

✍ Grant, Susan L; Hammacher, Annet; Douglas, Andrea M; Goss, Geraldine A; Mansfiel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 538 KB

Bidirectional interactions between the e

Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/

Modulation of the estrogen-regulated pro

Modulation of the estrogen-regulated proteins cathepsin D and pS2 by opioid agonists in hormone-sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems

✍ Simone Panagiotou; Anastassia Hatzoglou; Fabien Calvo; Pierre-Marie Martin; Elia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 3 views

In many cancer cell lines, including breast, prostate, lung, brain, head and neck, retina, and the gastrointestinal tract, opioids decrease cell proliferation in a dose-dependent and reversible manner. Opioid and/or other neuropeptide receptors mediate this decrease. We report that only the steroid-